期刊文献+

心力衰竭防治领域的进展与思考 被引量:5

下载PDF
导出
摘要 心力衰竭是影响人类寿命的全球性重大健康问题,积极寻求对其的防治方法一直是心血管治疗学领域的研究热点。2014年11月出版的《Lancet》发表了国际著名心脏病学专家Braunwald教授的关于心力衰竭治疗新方法的综述文章,本文基于此文同时结合近年来心力衰竭防治领域的相关进展做出思考与展望。
出处 《医学研究杂志》 2015年第8期6-8,共3页 Journal of Medical Research
基金 国家自然科学基金资助项目(81273932) 北京市优秀博士学位论文指导教师科技项目(20138450201)
  • 相关文献

参考文献17

  • 1陈可冀.人类寿命与慢性病中医药防治策略思考[J].中国中西医结合杂志,2014,34(8):901-902. 被引量:9
  • 2卫生部心血管病防治研究中心.中国心血管病报告2013[M].北京:中国大百科全书出版社,2014.
  • 3Mozaffarlan D, Benjamin E J, Go AS, et al. Heart disease and stroke statistics-2015 update: A report from the American Heart Association [ J ]. Circulation, 2015,131 : e2 - e294.
  • 4Braunwald E. The war against heart failure: the Lancet lecture [ J]. Lancet, 2015,385(9970) :812 -824.
  • 5Krum H. Heart failure: 10 Years of progress in HF research - what have we learned? [ J]. Nat Rev Cardiol, 2014, 11 (11) :631 -633.
  • 6Stamm C, Kleine HD, Choi YH, et al. Intramyocardial delivery of CD133 + bone marrow ceils and coronary artery bypass grafting for chronic isehemic heart disease: safety and efficacy studies[J]. J Tho- rae Cardiovasc Surg, 2007, 133 : 717 - 725.
  • 7Hare JM, Traverse JH, Henry TD, et al. A randomized, double - blind, placebo - controlled, dose - escalation study of intravenous a- dult human mesenehymal stem cells (proehymal) after acute myocar- dial infarction[ J]. J Am Coll Cardiel, 2009, 54:2277 -2286.
  • 8尤宏钊,张健.干细胞治疗心肌梗死和缺血性心力衰竭的临床应用进展[J].中国循环杂志,2014,29(6):476-478. 被引量:7
  • 9Tang WHW, Wang Z, Fan Y, et al. Prognostic value of elevated lev- els of intestinal microbe - generated metabolite trimethylamine - N - oxide in patients with heart failure: refining the gut hypothesls[ J ]. J Am Coll Cardiol,2014 ,64 :1908 - 1914.
  • 10冯新庆.超滤在心力衰竭治疗中的价值和展望[J].心血管病学进展,2014,35(1):5-8. 被引量:5

二级参考文献85

  • 1任晓庆,浦介麟,张澍,贾玉和,赵欣然,孟亮,王方正.自体骨髓间叶干细胞诱导分化移植重建窦房结起搏功能的实验研究[J].中国循环杂志,2004,19(6):462-465. 被引量:15
  • 2夏惠英.温阳活血利水方治疗心力衰竭利尿剂抵抗30例[J].中西医结合心脑血管病杂志,2005,3(10):920-920. 被引量:17
  • 3杨国胜,杨跃进,白东峰,杨伟宪,高润霖,陈在嘉.经冠状动脉移植骨髓间质干细胞治疗心肌梗死的实验研究[J].中国循环杂志,2007,22(1):20-23. 被引量:8
  • 4Blin G, Nury D, Stefanovic S, et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest, 2010, 120: 1125-1139.
  • 5Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126: 663-676.
  • 6Menasche P, Alfieri O, Janssens S,et al.The Myoblast Autologous Grafting in Isehemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.Circulation, 2008, 117:1189-200.
  • 7Zimmet H, Porapakkham P, Porapakkham P,et al. Short- and long- term outcomes of intraeoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials. Eur J Heart Fail, 2012, 14: 91-105.
  • 8Moccetti T, S u rder D, Klersy C, et al. Sustained improvement in left ventricular function after bone marrow derived cell therapy in patients with acute ST elevation myocardial infarction. A 5-year follow-up from the Stem Cell Transplantation in Ischaemic Myocardium Study. Swiss Med Wkly, 2012, 142: w13632.
  • 9Choi Y-H, Kurtz A, Starmn C. Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther, 2011, 22: 3-17.
  • 10Patel SA, Sherman L, Munoz J, et al. Immunological properties of mesenchymal stem eells and clinical implications. Arch Immunol Ther Exp, 2008, 56: 1-8.

共引文献845

同被引文献96

引证文献5

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部